Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
KOREA UNITED PHARM. INC.
🇰🇷
South Korea
Country
🇰🇷
South Korea
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Amosartan 5/50
Drug: UI15AML055MT
Subscribe
First Posted Date
2014-06-18
Last Posted Date
2015-06-12
Lead Sponsor
Korea United Pharm. Inc.
Target Recruit Count
46
Registration Number
NCT02166398
Locations
🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Subscribe
Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis
Phase 3
Completed
Conditions
Acute Bronchitis
Interventions
Drug: KALOMIN™ Tab.
Drug: Umckamin syrup
Subscribe
First Posted Date
2014-05-30
Last Posted Date
2014-05-30
Lead Sponsor
Korea United Pharm. Inc.
Target Recruit Count
242
Registration Number
NCT02151734
Subscribe
Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation
Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Anplag
Drug: UI03SPG300CT
Subscribe
First Posted Date
2013-04-26
Last Posted Date
2013-04-26
Lead Sponsor
Korea United Pharm. Inc.
Target Recruit Count
50
Registration Number
NCT01841086
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy